Congress Asset Management Co. Increases Stock Position in Integer Holdings Co. (NYSE:ITGR)

Congress Asset Management Co. grew its position in Integer Holdings Co. (NYSE:ITGR - Free Report) by 2.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 498,350 shares of the medical equipment provider's stock after purchasing an additional 9,565 shares during the quarter. Congress Asset Management Co. owned approximately 1.49% of Integer worth $66,041,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Loomis Sayles & Co. L P boosted its stake in shares of Integer by 3.0% in the 3rd quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider's stock valued at $69,943,000 after purchasing an additional 15,446 shares during the last quarter. Jane Street Group LLC boosted its stake in shares of Integer by 23.3% in the 3rd quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider's stock valued at $19,682,000 after purchasing an additional 28,572 shares during the last quarter. Verition Fund Management LLC boosted its stake in shares of Integer by 17.4% in the 3rd quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider's stock valued at $451,000 after purchasing an additional 515 shares during the last quarter. Versant Capital Management Inc boosted its stake in shares of Integer by 98.4% in the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock valued at $49,000 after purchasing an additional 183 shares during the last quarter. Finally, Lord Abbett & CO. LLC boosted its stake in Integer by 3.5% during the third quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider's stock worth $37,716,000 after acquiring an additional 9,754 shares in the last quarter. 99.29% of the stock is owned by institutional investors.

Integer Stock Up 1.6 %

ITGR traded up $2.25 during trading on Wednesday, hitting $143.40. 588,421 shares of the company's stock were exchanged, compared to its average volume of 228,807. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The business's 50 day moving average is $137.92 and its two-hundred day moving average is $132.20. Integer Holdings Co. has a fifty-two week low of $97.49 and a fifty-two week high of $146.36. The stock has a market cap of $4.81 billion, a P/E ratio of 44.26, a PEG ratio of 1.80 and a beta of 1.13.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Citigroup increased their target price on shares of Integer from $130.00 to $145.00 and gave the stock a "neutral" rating in a research note on Wednesday, December 11th. Truist Financial increased their target price on shares of Integer from $147.00 to $163.00 and gave the stock a "buy" rating in a research note on Wednesday, December 11th. KeyCorp increased their target price on shares of Integer from $144.00 to $154.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Piper Sandler reissued an "overweight" rating and set a $140.00 target price (up from $125.00) on shares of Integer in a research note on Friday, October 25th. Finally, Wells Fargo & Company reissued an "overweight" rating and set a $160.00 target price on shares of Integer in a research note on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $146.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.